4.6 Review

Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage

Journal

SEMINARS IN CANCER BIOLOGY
Volume 21, Issue 4, Pages 276-282

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2011.09.002

Keywords

Neuroblastoma; Differentiation; Hypoxia; Sympathetic nervous system; Tumor stem cells

Categories

Funding

  1. Swedish Cancer Society
  2. Children's Cancer Foundation of Sweden
  3. Swedish Research Council
  4. Swedish Foundation for Strategic Research (SSF) Strategic Center for Translational Cancer Research-CREATE Health
  5. BioCARE, Gunnar Nilsson's Cancer Foundation
  6. Malmo University Hospital

Ask authors/readers for more resources

Neuroblastoma is a childhood malignancy of the sympathetic neuronal lineage. It is a rare disease, but since it is frequently diagnosed during infancy, neuroblastoma causes life-long medical follow up of those children that survive the disease. It was early recognized that a high tumor cell differentiation stage correlates to favorable clinical stage and positive clinical outcome. Today, highly differentiated tumors are surgically removed and not further treated. Cells of many established human neuroblastoma cell lines have the capacity to differentiate when stimulated properly, and these cell lines have been used as models for studying and understanding central concepts of tumor cell differentiation. One recent aspect of this issue is the observation that tumor cells can dedifferentiate and gain a stem cell-like phenotype during hypoxic conditions, which was first shown in neuroblastoma. Aberrant or blocked differentiation is a central aspect of neuroblastoma genesis. In this review we summarize known genetic and non-genetic events in neuroblastoma that might be coupled to an aberrant sympathetic neuronal differentiation and thereby indirectly influencing tumorigenesis and/or aggressive neuroblastoma behavior. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available